ResMed is a global manufacturer of CPAP masks, machines and other products that diagnose, treat or help manage sleep-disordered breathing (particularly sleep apnea), chronic obstructive pulmonary disease (COPD), or other respiratory conditions. For the general public, the company offers a non-contact sleep monitor, the S+ by ResMed, currently available in the US.
ResMed employs about 5,000 employees worldwide, operates in 100 countries and has manufacturing facilities in Australia, France, Singapore and the US. It achieved revenues of $1.7 billion USD in fiscal year 2014–15.
As part of its mission, ResMed seeks to spread awareness of the prevalence of sleep-disordered breathing (SDB) and its major manifestation, obstructive sleep apnea (OSA), since more than 80% of cases are believed to be undiagnosed. More than 70% of people with obesity, heart failure, type 2 diabetes, and drug-resistant hypertension have some form of sleep-disordered breathing.